Clinical efficacy and nocebo effect following non-medical biosimilar switch in patients with inflammatory bowel disease: A prospective observational study
Panu Wetwittayakhlang, Khaled Karkout, Arti Wongcha-um, Paraskevi Tselekouni, Reem Al-Jabri, Waqqas Afif, Gary Wild, Alain Bitton, Talat Bessissow, Péter L. Lakatos
Topics & Concepts
MedicineBiosimilarNoceboInternal medicineDiscontinuationInflammatory bowel diseaseNocebo EffectCalprotectinObservational studyBiomarkerProspective cohort studyAdverse effectTherapeutic drug monitoringUlcerative colitisClinical trialAdalimumabDrugInfliximabDiseasePlaceboPharmacologyPathologyPharmacokineticsChemistryAlternative medicineBiochemistryBiosimilars and Bioanalytical MethodsInflammatory Bowel DiseasePharmacogenetics and Drug Metabolism